
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
SSE:688621.SS
Overview | Financials
Company Name | Beijing Sun-Novo Pharmaceutical Research Co., Ltd. |
Symbol | 688621.SS |
Currency | CNY |
Price | 54.23 |
Market Cap | 6,073,760,000 |
Dividend Yield | 0% |
52-week-range | 28.9 - 59.98 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yujing Liu |
Website | https://www.sun-novo.com |
An error occurred while fetching data.
About Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD